We specialize in the interface between infectious diseases and gut microbiota health
Houston, TX
Joined March 2018
- Tweets207
- Following243
- Followers282
- Likes276
The Garey Lab retweeted
Microbiome stewardship is an emerging extension of antimicrobial stewardship, aiming to safeguard human health and environment from collateral damage of antibiotics.
Here, we discuss practical principles for selecting Microbiome-friendly antibiotics!
sciencedirect.com/science/ar…
The Garey Lab retweeted
Invitation: 9th Annual Texas Medical Center Antimicrobial Resistance and Stewardship Conference, Jan. 14-16, 2026 - mailchi.mp/ba6f3367b98d/call…
We are recruiting for an Infectious Diseases Pharmacotherapy Fellow! 🦠🔬Please see the job posting and more information to apply here: sidp.mcjobboard.net/jobs/205…
Exciting Phase 2b results out now in @LancetMicrobe for ibezapolstat! Check it out! 👏🏻 ⬇️
sciencedirect.com/science/ar…
The Garey Lab retweeted
Curious how the microbiome impacts chronic diseases like hypertension? 🤔Check out our scoping review published in @Nutrients_MDPI
mdpi.com/2072-6643/17/5/825
Curious how the microbiome impacts chronic diseases like hypertension? 🤔Check out our scoping review published in @Nutrients_MDPI
mdpi.com/2072-6643/17/5/825
The Garey Lab retweeted
🆕️✨️ @OFIDJournal
Defining fulminant Clostridioides difficile infections: Assessing the utility of hypotension as a diagnostic criterion #IDXposts academic.oup.com/ofid/articl…
🚨HOT TO PRESS🚨
Check out past fellow Hubert Chua’s publication striving to better define hypotension definitions for fulminant CDI. 🫀🦠
doi.org/10.1093/ofid/ofaf033
Next up at poster #74, 3rd year pharmacy student Megan Huang Frazier will be presenting her findings from her systematic review exploring clinical benefit of utilizing 125mg vs 250mg PO Vanc for CDI🦠Stop by and show her support! #GCCAMR2025 @UH_Pharmacy
Last day at #GCCAMR2025 but still more posters & exciting research! Check out poster #65 today on leveraging publicly available genomic data for biomarkers associated with PolC-inhibitor resistance by Jacob McPherson 🧬
Also presenting today stop by poster #36 to learn how Chenlin is developing and validating a practical and accurate liquid chromatography-tandem mass spectrometry (LC-MS/MS) technique to quantify fidaxomicin and active metabolite, OP-1118, in human feces 💊 #GCCAMR2025
More posters!! Check out Thanh Le's poster investigating if vancomycin resistance in C. difficile confers fitness cost?? Drop by to ask her more!!
Check out @JFowlerUHCOP poster (#11) at today's #GCCAMR2025 poster session! PPIs are a risk factor for CDI and other infections...but why?? 🤔💊 Let Josef give you some thoughts!
Love seeing our fellow UHCOP colleagues and collaborators thriving! @MsdiShremo 👏👏👏
Check out the interview over his recent PK publication!
In the second part of our conversation, Abdulwhab Shremo Msdi, PharmD, discusses using this methodology. #IDtwitter
contagionlive.com/view/estim…
We are excited for the Annual TMC AMR & Stewardship Research Conference starting TOMORROW!! We will be live tweeting updates and showcasing our lab member's work!! Stay tuned!!
amr25.blogs.rice.edu/ @GCCAMR
Why are proton pump inhibitors associated with increased infection risk?? 🤔That's what we asked!! Check out @JFowlerUHCOP systematic review on PPI impact on macrophage and neutrophil function here: frontiersin.org/articles/10.….
Check out our publication on an innovative assay that holds significant potential for applications in public health, infection control, diagnostic, and therapeutic strategies related to CDI! 💡@GareyKgarey @jinheej08 doi.org/10.1128/spectrum.016…
Dr. Eubank recently was awarded the SIDP New Investigator Grant! Check out the article below to learn more about her exciting research at The Garey Lab 🥼🧪 uh.edu/pharmacy/news-and-eve…
